Bracco, Colowatch Team Up to Expand the Availability of Virtual ...
Nov. 20, 2024 — Bracco Diagnostics Inc. and ColoWatch have announced a new partnership to deliver a turnkey solution for ...
Blue Earth Therapeutics Reports Promising Phase 1 Data for ...
Blue Earth Therapeutics Ltd, recently announced further positive developments for its novel investigational radioligand ...
Blue Earth Diagnostics, a Bracco Company, Announces Results Evaluating ...
July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...
Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as ...
July 9, 2024 — Bracco and Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
Blue Earth Diagnostics Announces Agreement with Siemens Healthineers ...
May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...
Market Analysis: Vendor Focus on Optimizing Patient Safety and ...
Contrast media injectors are used to inject contrast media or contrast agents to enhance the blood and perfusion in ...
The European Commission Grants Marketing Authorization to Bracco ...
December 11, 2023 — Bracco Imaging S.p.A., an innovative world leader delivering end-to-end products and solutions ...
Bracco Diagnostics Showcases Innovation and Collaborative Vision at ...
November 13, 2023 — Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a pioneer in diagnostic ...
5 Trends in Radiation Dose Management
Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ...
Blue Earth Diagnostics Announces Addition of POSLUMA (Flotufolastat F ...
July 28, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...